Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | IO-202 |
Trade Name | |
Synonyms | IO202|IO 202 |
Drug Descriptions |
IO-202 is a monoclonal antibody against LILRB4, which blocks downstream signaling, potentially resulting in activation of innate immune responses and inhibition of tumor growth (Blood 2020 Nov 5, 136 (Supplement 1):19-20). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C174485 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Azacitidine + IO-202 | Azacitidine IO-202 | 0 | 1 |
Azacitidine + IO-202 + Venetoclax | Azacitidine IO-202 Venetoclax | 0 | 1 |
IO-202 | IO-202 | 0 | 2 |
IO-202 + Pembrolizumab | IO-202 Pembrolizumab | 0 | 1 |